EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Unraveling Novel Prospective Inhibitors of Streptococcus pneumoniae Chorismate Synthase by Pharmacophore Screening, Docking Analysis and Molecular Dynamics Simulation Studies

Donanakatte Mallikarjun Anusha, Surjit Bhattacharjee, Gummuluri Meher Unnati, Roopika Azhagisan, Tanos Celmar Costa Franca, Steven R. LaPlante, Ou Zhang, Neelam Mishra

Biophysica · 31.07.2026 · 6 (4) · 69

DOI: 10.3390/biophysica6040069 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biophysica, online erschienen am 31.07.2026. Verfasst von Donanakatte Mallikarjun Anusha und 7 weiteren Autor:innen. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Streptococcus pneumoniae is the major causative agent of community-acquired pneumonia, one of the main infectious diseases that causes inflammation in the alveoli and leads to significant morbidity and mortality across various age groups. Current treatments are challenged by multidrug-resistant strains of S. pneumoniae, which has led to the reemergence of pneumonia in recent years; therefore, it is pivotal to identify new drug targets. The enzyme chorismate synthase (CS), involved in the shikimate pathway of S. pneumoniae, aids in the synthesis of vital aromatic amino acids and other metabolites required for bacterial viability. The present study identifies natural compounds that can inhibit CS using an in silico approach, including pharmacophore modeling, virtual screening, molecular docking, ADME analysis, and molecular dynamics (MD) simulations. Our results suggest that the identified compounds can bind effectively to the active site of S. pneumoniae CS (SpCS), exhibiting affinities better than the known inhibitor 1-benzofuran-3-one and close to the enzyme’s natural substrate, 5-enolpyruvylshikimate-3-phosphate (EPSP). This study suggests lead natural compounds as promising candidates for further investigation as potential inhibitors for the treatment of pneumonia, offering a novel strategy to combat this resilient pathogen.

Zitieren

APA

Anusha, D. M., Bhattacharjee, S., Unnati, G. M., Azhagisan, R., Franca, T. C. C., LaPlante, S. R., Zhang, O., & Mishra, N. (2026). Unraveling Novel Prospective Inhibitors of Streptococcus pneumoniae Chorismate Synthase by Pharmacophore Screening, Docking Analysis and Molecular Dynamics Simulation Studies. Biophysica, 6(4), 69. https://doi.org/10.3390/biophysica6040069

Vancouver

Anusha DM, Bhattacharjee S, Unnati GM, Azhagisan R, Franca TCC, LaPlante SR, et al. Unraveling Novel Prospective Inhibitors of Streptococcus pneumoniae Chorismate Synthase by Pharmacophore Screening, Docking Analysis and Molecular Dynamics Simulation Studies. Biophysica. 2026;6(4):69. doi:10.3390/biophysica6040069

BibTeX
@article{Anusha2026,
  author = {Anusha, Donanakatte Mallikarjun and Bhattacharjee, Surjit and Unnati, Gummuluri Meher and Azhagisan, Roopika and Franca, Tanos Celmar Costa and LaPlante, Steven R. and Zhang, Ou and Mishra, Neelam},
  title = {Unraveling Novel Prospective Inhibitors of Streptococcus pneumoniae Chorismate Synthase by Pharmacophore Screening, Docking Analysis and Molecular Dynamics Simulation Studies},
  journal = {Biophysica},
  year = {2026},
  volume = {6},
  number = {4},
  pages = {69},
  doi = {10.3390/biophysica6040069}
}
Kostenlos starten →